Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
69.1M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
1.67M
-
Shares change
-
+158K
-
Total reported value, excl. options
-
$25.3M
-
Value change
-
+$2.52M
-
Put/Call ratio
-
0.36
-
Number of buys
-
21
-
Number of sells
-
-12
-
Price
-
$15.13
Significant Holders of PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share (PLSE) as of Q2 2018
51 filings reported holding PLSE - PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share as of Q2 2018.
PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share (PLSE) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.67M shares
of 69.1M outstanding shares and own 2.42% of the company stock.
Largest 10 shareholders include BlackRock Inc. (600K shares), VANGUARD GROUP INC (258K shares), STATE STREET CORP (133K shares), NORTHERN TRUST CORP (107K shares), GEODE CAPITAL MANAGEMENT, LLC (70.4K shares), WELLS FARGO & COMPANY/MN (64.8K shares), Bank of New York Mellon Corp (61.6K shares), MORGAN STANLEY (35.5K shares), Silverleafe Capital Partners, LLC (33K shares), and AQR CAPITAL MANAGEMENT LLC (32.5K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.